OX40 is required for regulatory T cell-mediated control of colitis

Thibault Griseri, Mark Asquith, Claire Thompson, Fiona Powrie, Thibault Griseri, Mark Asquith, Claire Thompson, Fiona Powrie

Abstract

The immune response in the gastrointestinal tract is a tightly controlled balance between effector and regulatory cell responses. Here, we have investigated the role of OX40 in influencing the balance between conventional T cells and Foxp3+ regulatory T (T reg) cells. Under steady-state conditions, OX40 was required by T reg cells for their accumulation in the colon, but not peripheral lymphoid organs. Strikingly, under inflammatory conditions OX40 played an essential role in T reg cell-mediated suppression of colitis. OX40(-/-) T reg cells showed reduced accumulation in the colon and peripheral lymphoid organs, resulting in their inability to keep pace with the effector response. In the absence of OX40 signaling, T reg cells underwent enhanced activation-induced cell death, indicating that OX40 delivers an important survival signal to T reg cells after activation. As OX40 also promoted the colitogenic Th1 response, its expression on T reg cells may be required for effective competition with OX40-dependent effector responses. These results newly identify a key role for OX40 in the homeostasis of intestinal Foxp3+ T reg cells and in suppression of colitis. These fi ndings should be taken into account when considering OX40 blockade for treatment of IBD.

Figures

Figure 1.
Figure 1.
OX40 is preferentially expressed on intestinal T cells and promotes Foxp3+ T reg cell accumulation in the colon in a cell intrinsic way. (A, left) Tissues from WT mice analyzed by flow cytometry for CD4, Foxp3, and OX40 expression. Percentages of OX40+ cells among CD4+ Foxp3− or Foxp3+ cells are indicated in representative dot plots (n = 5). (right) OX40L mRNA amounts in spleen, MLN, and total colon homogenate (n = 5). Values are normalized to CD45 and are mean values (± SEM) relative to spleen (set to 1). (B) Percentages and total numbers of Foxp3− and Foxp3+ CD4 T cells in tissues of WT and OX40−/− mice. (C) BM cells from WT congenic mice (CD45.1+) mixed in equal proportion with BM cells from OX40−/− mice (CD45.2+) were injected i.v. into irradiated RAG−/− mice. 8 wk after transfer, tissues were harvested and stained for TCR-β, CD45.2, and Foxp3. Representative staining (top) and the ratio of WT/OX40−/− progeny among TCRαβ+ cells are shown (bottom). Each point represents an individual mouse and horizontal bars represent group means (B and C). Data are representative of two to three independents experiments.
Figure 2.
Figure 2.
OX40 expression on T reg cells is required to suppress T cell induced colitis. RAG−/− mice received WT CD4+CD45RBhi T cells alone (no TR), or in combination with WT or OX40−/− CD4+CD25+ T reg cells (TR). (A) Mean weight of six animals per group (± SEM). (B) Colitis score at 8 wk. An additional control group showed that OX40−/− T reg cells do not induce colitis by themselves. (C) Photomicrographs of mid-colon sections. Bar, 100 µm. (D) Number of colonic IFN-γ+ and IL-17+CD4+ T cells, neutrophils (CD11c−CD11bhiGr1hiSSChi) and monocytes/macrophages (CD11c−CD11bhiGr1intSSClo) at 8 wk. Each point represents an individual mouse and horizontal bars represent group means (B and D). Results are representative of three independent experiments.
Figure 3.
Figure 3.
OX40 is required for early Foxp3+ T reg cell accumulation in the lymphoid organs and colon during control of intestinal inflammation. (A) CD45.1+ CD4+CD45RBhi T cells were cotransferred with CD45.2+ WT or OX40−/− T reg cells (TR) into RAG−/− mice. Numbers and percentages of CD45.2+CD4+Foxp3+ cells in tissues 2 wk (B) and 8 wk (C) after cotransfer. Each point represents an individual mouse. Data are representative of three independent experiments.
Figure 4.
Figure 4.
Phenotypic and functional characteristics of WT and OX40−/− T reg cells after transfer. CD45.1+ CD4+CD45RBhi T cells were transferred with CD45.2+ WT or OX40−/− T reg cells (TR) into RAG−/− mice. (A) Ki67 expression in cLPL and MLN and α4β7 integrin expression in MLN on Foxp3+ T reg progeny at wk 2. (B) Foxp3, CD25, CD44, CD62L expression, IL-17, and IFN-γ secretion by Foxp3+ T reg progeny at wk 8 in cLPL. (C) GITR expression by Foxp3+ T reg progeny at 2 wk (dot plots) and 8 wk (graph) and CD4+ T cells from the spleen of normal mice (dot plots). Percentages of GITRhi cells among CD4+Foxp3+ cells and GITR MFI on Foxp3+GITR+cells are indicated in dot plots. Data are representative of two independent experiments.
Figure 5.
Figure 5.
Lack of an OX40 signal renders activated T reg cells more susceptible to apoptosis. WT or OX40−/− CD25+ FACS sorted T reg cells were cultured in triplicate for 5 d with irradiated APC and soluble anti-CD3, in the presence of an anti-OX40L mAb or isotype control. hIL-2 was added to the cultures (200U/ml). (A) Representative dot plots of CFSE dilution by CD4+Foxp3+ cells. Bar graphs represent means of Ki67 expression by Foxp3+ cells and total number of CD4+Foxp3+ cells at d 5 (mean of triplicate cultures ± SD). (B) Representative Annexin V-7 ADD staining 5 d after T reg cell activation (gated on CD4+ T cells). Bar graph represents mean percentages of apoptotic cells (mean of triplicate cultures ± SD). **, P < 0.001. Results are representatives of two to three independent experiments. (C) CD4+CD45RBhi T cells were transferred into RAG−/− mice with CD25+ TR cells isolated from WT or OX40−/− Foxp3-GFP mice. Numbers in dot plots represent the percentages of Annexin V+ cells at 2 wk among colonic CD4+Foxp3(GFP)+ cells, after overnight culture in medium. Three to four colons were pooled per group, and results are representative of two independent experiments.
Figure 6.
Figure 6.
OX40 is required for the development of colitogenic T cell responses. RAG−/− mice received CD4+CD45RBhi T cells from WT or OX40−/− donors. (A) Mean weight loss (n = 6 ± SEM) and colitis score at wk 8. Representative photomicrographs of mid-colon sections are shown below. Bar, 100 µm. (B) Amount of OX40L mRNA in total colon homogenate from untransferred mice (RAG−/−) or colitic mice (RBhi) at wk 8. Data shown are the mean values (n = 4) relative to untransferred RAG−/− mice (set to 1), after normalization to HPRT expression. (C) Number of colonic IFN-γ+ and IL-17+ CD4+ T cells 8 wk after transfer. Each point in (A, right) and (C) represents an individual mouse. Results are representative of three independent experiments.

References

    1. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., Ochs H.D. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20–21 10.1038/83713
    1. Bouma G., Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521–533 10.1038/nri1132
    1. Cederbom L., Hall H., Ivars F. 2000. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30:1538–1543 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>;2-X
    1. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., Rudensky A.Y. 2009. CD4+ Regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 326:986–991
    1. Chen Q., Davidson T.S., Huter E.N., Shevach E.M. 2009. Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J. Immunol. 183:4458–4466 10.4049/jimmunol.0901465
    1. Coombes J.L., Robinson N.J., Maloy K.J., Uhlig H.H., Powrie F. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204:184–194 10.1111/j.0105-2896.2005.00250.x
    1. Croft M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609–620 10.1038/nri1148
    1. Darrasse-Jèze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., Masilamani R.F., Dustin M.L., Rudensky A., Liu K., Nussenzweig M.C. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853–1862 10.1084/jem.20090746
    1. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329–341 10.1016/j.immuni.2005.01.016
    1. Golovina T.N., Mikheeva T., Suhoski M.M., Aqui N.A., Tai V.C., Shan X., Liu R., Balcarcel R.R., Fisher N., Levine B.L., et al. 2008. CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 181:2855–2868
    1. Hippen K.L., Harker-Murray P., Porter S.B., Merkel S.C., Londer A., Taylor D.K., Bina M., Panoskaltsis-Mortari A., Rubinstein P., Van Rooijen N., et al. 2008. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood. 112:2847–2857 10.1182/blood-2008-01-132951
    1. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., Liu Y.J. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202:1213–1223 10.1084/jem.20051135
    1. Izcue A., Hue S., Buonocore S., Arancibia-Cárcamo C.V., Ahern P.P., Iwakura Y., Maloy K.J., Powrie F. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 28:559–570 10.1016/j.immuni.2008.02.019
    1. Izcue A., Coombes J.L., Powrie F. 2009. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27:313–338 10.1146/annurev.immunol.021908.132657
    1. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595–602 10.1038/ni.1731
    1. Malmström V., Shipton D., Singh B., Al-Shamkhani A., Puklavec M.J., Barclay A.N., Powrie F. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166:6972–6981
    1. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., Powrie F. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111–119 10.1084/jem.20021345
    1. Onishi Y., Fehervari Z., Yamaguchi T., Sakaguchi S. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA. 105:10113–10118 10.1073/pnas.0711106105
    1. Pfaffl M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45 10.1093/nar/29.9.e45
    1. Piconese S., Valzasina B., Colombo M.P. 2008. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 205:825–839 10.1084/jem.20071341
    1. Pippig S.D., Peña-Rossi C., Long J., Godfrey W.R., Fowell D.J., Reiner S.L., Birkeland M.L., Locksley R.M., Barclay A.N., Killeen N. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:6520–6529
    1. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1:553–562 10.1016/1074-7613(94)90045-0
    1. Ruby C.E., Montler R., Zheng R., Shu S., Weinberg A.D. 2008. IL-12 is required for anti-OX40-mediated CD4 T cell survival. J. Immunol. 180:2140–2148
    1. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. 2008. Regulatory T cells and immune tolerance. Cell. 133:775–787 10.1016/j.cell.2008.05.009
    1. Sather B.D., Treuting P., Perdue N., Miazgowicz M., Fontenot J.D., Rudensky A.Y., Campbell D.J. 2007. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204:1335–1347 10.1084/jem.20070081
    1. Shevach E.M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 30:636–645 10.1016/j.immuni.2009.04.010
    1. Shevach E.M., Stephens G.L. 2006. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6:613–618 10.1038/nri1867
    1. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135–142 10.1038/ni759
    1. Song J., So T., Cheng M., Tang X., Croft M. 2005. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity. 22:621–631 10.1016/j.immuni.2005.03.012
    1. Souza H.S., Elia C.C., Spencer J., MacDonald T.T. 1999. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 45:856–863
    1. Sugamura K., Ishii N., Weinberg A.D. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4:420–431 10.1038/nri1371
    1. Takeda I., Ine S., Killeen N., Ndhlovu L.C., Murata K., Satomi S., Sugamura K., Ishii N. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172:3580–3589
    1. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., Bluestone J.A. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 28:687–697 10.1016/j.immuni.2008.03.016
    1. Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A.D., Colombo M.P. 2005. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood. 105:2845–2851 10.1182/blood-2004-07-2959
    1. van Olffen R.W., Koning N., van Gisbergen K.P., Wensveen F.M., Hoek R.M., Boon L., Hamann J., van Lier R.A., Nolte M.A. 2009. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 182:7490–7500 10.4049/jimmunol.0802751
    1. Vu M.D., Xiao X., Gao W., Degauque N., Chen M., Kroemer A., Killeen N., Ishii N., Chang Li X. 2007. OX40 costimulation turns off Foxp3+ Tregs. Blood. 110:2501–2510 10.1182/blood-2007-01-070748
    1. Wan Y.Y., Flavell R.A. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 445:766–770 10.1038/nature05479
    1. Watts T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23–68 10.1146/annurev.immunol.23.021704.115839
    1. Yuan Q., Bromley S.K., Means T.K., Jones K.J., Hayashi F., Bhan A.K., Luster A.D. 2007. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204:1327–1334 10.1084/jem.20062076
    1. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 458:351–356 10.1038/nature07674

Source: PubMed

3
订阅